Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) FCF Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed FCF Margin for 16 consecutive years, with 3.38% as the latest value for Q1 2026.

  • Quarterly FCF Margin fell 318.0% to 3.38% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 2.42% through Jan 2026, down 472.0% year-over-year, with the annual reading at 2.42% for FY2026, 472.0% down from the prior year.
  • FCF Margin for Q1 2026 was 3.38% at Usana Health Sciences, up from 2.41% in the prior quarter.
  • The five-year high for FCF Margin was 13.91% in Q4 2022, with the low at 2.41% in Q3 2025.
  • Average FCF Margin over 5 years is 6.31%, with a median of 6.06% recorded in 2022.
  • The sharpest move saw FCF Margin soared 721bps in 2022, then plummeted -1306bps in 2025.
  • Over 5 years, FCF Margin stood at 13.28% in 2022, then crashed by -56bps to 5.84% in 2023, then grew by 12bps to 6.56% in 2024, then crashed by -137bps to 2.41% in 2025, then soared by 240bps to 3.38% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods came in at 3.38%, 2.41%, and 1.87% for Q1 2026, Q3 2025, and Q2 2025 respectively.